Premium Information is available for this item - Upgrade for $1 a day

6505-01-629-9889

Fentanyl Citrate Transmucosal Lo

6505016299889 016299889 ACTIQ 800MCG 8106992

INC: 77777

6505-01-629-9889 FENTANYL CITRATE TRANSMUCOSAL LO 6505016299889 016299889

Managed by United States
NSN Created on 22 Jul 2014
Data Last Changed
January 2023
NATO Update Count
6
NATO Data Quality
6505-01-629-9889 FENTANYL CITRATE TRANSMUCOSAL LO 6505016299889 016299889 1/1
NSN 6505-01-629-9889 (Generic Image) 1/1

6505-01-629-9889 Stock and Availability Marketplace 6505-01-629-9889

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-01-629-9889 RQST NE eBay
eBay Updated Every Day
6505-01-629-9889 RQST eBay
Amazon Updated Every Day
6505-01-629-9889 RQST NE Amazon

6505-01-629-9889 Related Documents Related Documents 6505-01-629-9889 5+ Documents (More...)

ACTIQ 800MCG 8106992 Managed by United States NSN Created on 22 Jul 2014 Data Last Changed January 2023
6505-01-629-9889 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-629-9889
/fsg-65/fsc-6505/us 6505-01-629-9889 /fsg-65/fsc-6505/us 6505-01-629-9889 /fsg-65/fsc-6505/us 6505-01
instructions how to enable JavaScript in your web browser . 5330-15-142-2565Anello5330151422565 151422565 8106992
https//www.nsnlookup.com /fsg-53/fsc-5330/it 5330-15-142-2565 Anello 5330151422565 151422565,8106992 8106992
vendors Request Updated Every Day 5330-15-142-2565 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-629-9889
99-238-1508Fentanyl Lozenge6505992381508 https/ https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-629-9889
Fentanyl Citrate Transmucosal Lo 016299889 Upgrade your Account Upgrade 6505-01-629-9889Fentanyl
Citrate Transmucosal Lo6505016299889 016299889 ACTIQ /www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-
enable JavaScript in your web browser . 6505-99-241 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-629-9889
Fentanyl Citrate Transmucosal Lo 016299889 Upgrade your Account Upgrade 6505-01-629-9889Fentanyl
Citrate Transmucosal Lo6505016299889 016299889 ACTIQ /www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-
490-4137Fentanyl Lozenges6505994904137 994904137 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-629-9889
Fentanyl Citrate Transmucosal Lo 016299889 Upgrade your Account Upgrade 6505-01-629-9889Fentanyl
Citrate Transmucosal Lo6505016299889 016299889 ACTIQ /www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-

6505-01-629-9889 Demil Restrictions 6505-01-629-9889

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: A | EDC: A | ADPEC: 0

6505-01-629-9889 is a Fentanyl Citrate Transmucosal Lo that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.

6505-01-629-9889 End Users End Users 6505-01-629-9889

Australia (ZA01)
Effective Date:
1 Jul 2014

6505-01-629-9889 Manufacturers Approved Sources 6505-01-629-9889

6505-01-629-9889 Technical Data Datasheet 6505-01-629-9889

Characteristic
Specifications
FIIG
A23900
Part Name Assigned By Controlling Agency [CXCY]
Actiq Lozenge W/ Integral Applicator 800 Mcg
Unit Package Quantity [AGUC]
9
Special Features [FEAT]
Similar Decs. And Dosage To Pre.Est. Nsn 6505-01-578-9755

6505-01-629-9889 Similar Items Similar Supply Items to 6505-01-629-9889

6505-01-629-9889 Freight Data Freight Information 6505-01-629-9889

6505-01-629-9889 has freight characteristics managed by Australia.. 6505-01-629-9889 has a variance between NMFC and UFC when transported by rail and the description should be consulted.